MRI-guided risk-based pacing for heart failure with reduced ejection fraction
Official title: Magnetic Resonance Imaging Based Risk Stratification for Defibrillator Implantation in Heart Failure Patients Requiring Cardiac Resynchronization Therapy (MADURAI CRT)
Run by Velammal Medical College Hospital and Research Institute · NCT07791407 · Data updated 2026-11-12
This study tests whether left bundle branch pacing without a defibrillator works as well as traditional CRT with defibrillator in people with a specific heart failure and MRI-detected low risk of scar.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 114 (estimated) |
| Sponsor | Velammal Medical College Hospital and Research Institute Academic / other |
| Locations | 1 site (Madurai, Tamil Nadu) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | July 15, 2027 |
| Study ends | July 15, 2028 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT07791407 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults ≥18 with non-ischemic cardiomyopathy, LVEF ≤35%, typical LBBB, and HF symptoms despite GDMT.
✕Probably not a fit
Patients with significant scar or high-risk imaging, alternative anatomy, or inability to undergo CMR may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective, randomized trial enrolling adults with non-ischemic cardiomyopathy, LVEF ≤35%, and heart failure symptoms despite GDMT. Participants undergo contrast-enhanced CMR to stratify risk by scar burden; low-risk patients (scar absent or <5%) are randomized 1:1 to LBBP without defibrillator or CRT-D with biventricular pacing. The LBBP procedure uses a 3830 lead via a proximal IVS approach, with fallback CS-based BiV pacing if LBBP is unsuccessful; in CRT-D arms, postero-lateral CS lead placement and a defibrillator lead are used. Primary endpoints focus on pacing effectiveness and clinical outcomes, with feasibility of alternative pacing strategies in case of technical failure. Inclusion criteria include adults ≥18 with typical LBBB and LVEF ≤35%, while key exclusions involve significant CAD requiring revascularization, non-LBBB patterns, pregnancy, contrast allergy, and other conditions limiting protocol adherence.
Why it matters
Potential benefit: If successful, patients could receive effective pacing without a defibrillator, potentially reducing device-related risks and complications.
How similar studies have gone: Previous pacing strategies have shown promise but this specific MRI-guided, scar-stratified comparison is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with age ≥18 years 2. Typical left bundle branch block as defined by Strauss criteria with LVEF ≤35% 3. Heart failure symptoms despite guideline directed medical therapy (GDMT) Exclusion Criteria: 1. Patients with angiographic evidence of significant coronary artery disease requiring revascularisation. In patients with significant CAD, LVEF will be re-assessed 3 months after revascularisation to decide about CRT 2. Patients with associated uncorrected congenital or valvular heart disease 3. Expected life-expectance of \<12 months due to associated comorbidities 4. Patients with contrast allergy 5. Baseline non-LBBB morphology 6. Renal dysfunction which limits the acquisition of CMR with contrast 7. Pregnant or lactating women 8. Patients who are unable to comply with study protocol
Where it's running
-
Velammal Medical College Hospital and Research Institute
Madurai, Tamil Nadu, India Recruiting
Study contacts
- Study coordinator: Shunmuga Sundaram Ponnusamy, MD, FHRS
- Email: shunmuga.pgi@gmail.com
- Phone: +919444712846
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if stopping heart failure meds is safe for super-responders with non-ischemic cardiomyopathy and CRT
This trial tests whether stopping heart failure medications is safe in patients with non-ischemic cardiomyopathy who have had a strong positive response to CRT and meet specific genetic and imaging criteria.
-
Left bundle branch area pacing with multimodal guidance vs. conventional pacing for heart failure with complete left bundle branch block
A multicenter trial tests whether using multimodal data to guide left bundle branch area pacing helps people with heart failure and complete left bundle branch block, compared with traditional biventricular pacing.
-
Cardiac MRI for risk prediction in non-dilated left ventricular cardiomyopathy
This retrospective study will test whether findings on cardiac MRI can help predict serious heart problems in people with non-dilated left ventricular cardiomyopathy.
-
Registry and biobank of non-ischemic cardiomyopathy with linked heart imaging
This project will collect clinical data, heart images, ECGs, and blood samples from people with non-ischemic cardiomyopathy and at-risk relatives to try to build and test tools that predict arrhythmia risk and guide family screening.
-
Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People
This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.
-
Using a new cardiac device to treat heart failure with less invasive techniques
This study is testing a new heart device that can be implanted with less invasive methods to see if it helps people with heart failure feel better and improve heart function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.